Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 8.28
(-0.12%)
CNY 8.28
(-0.12%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.07 Billion CNY | 10.18% |
| 2022 | 2.77 Billion CNY | -14.98% |
| 2021 | 3.26 Billion CNY | 12.99% |
| 2020 | 2.89 Billion CNY | 4.14% |
| 2019 | 2.77 Billion CNY | 3.13% |
| 2018 | 2.69 Billion CNY | 5.8% |
| 2017 | 2.54 Billion CNY | 24.75% |
| 2016 | 2.04 Billion CNY | 22.23% |
| 2015 | 1.66 Billion CNY | 15.02% |
| 2014 | 1.45 Billion CNY | 20.52% |
| 2013 | 1.2 Billion CNY | 21.45% |
| 2012 | 991.52 Million CNY | 26.39% |
| 2011 | 784.49 Million CNY | 23.0% |
| 2010 | 637.79 Million CNY | 11.14% |
| 2009 | 573.85 Million CNY | 4.14% |
| 2008 | 551.04 Million CNY | 17.25% |
| 2007 | 469.97 Million CNY | 17.02% |
| 2006 | 401.61 Million CNY | 21.82% |
| 2005 | 329.68 Million CNY | 7.09% |
| 2004 | 307.84 Million CNY | 3.06% |
| 2003 | 298.69 Million CNY | 6.47% |
| 2002 | 280.55 Million CNY | 36.26% |
| 2001 | 205.9 Million CNY | 3.43% |
| 2000 | 199.07 Million CNY | -9.39% |
| 1999 | 219.71 Million CNY | 0.37% |
| 1998 | 218.9 Million CNY | 6.58% |
| 1997 | 205.38 Million CNY | -8.21% |
| 1996 | 223.76 Million CNY | 5.45% |
| 1995 | 212.19 Million CNY | 60.81% |
| 1994 | 131.95 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 707.7 Million CNY | 382.02% |
| 2024 Q1 | 587.73 Million CNY | -40.04% |
| 2024 Q2 | 146.82 Million CNY | -75.02% |
| 2023 Q3 | 725.17 Million CNY | 3.45% |
| 2023 Q2 | 700.96 Million CNY | 5.35% |
| 2023 Q4 | 980.26 Million CNY | 35.18% |
| 2023 FY | 3.06 Billion CNY | 10.18% |
| 2023 Q1 | 665.35 Million CNY | -2.07% |
| 2022 Q1 | 887.47 Million CNY | 9.18% |
| 2022 Q3 | 711.53 Million CNY | 42.29% |
| 2022 Q4 | 679.39 Million CNY | -4.52% |
| 2022 Q2 | 500.04 Million CNY | -43.66% |
| 2022 FY | 2.77 Billion CNY | -14.98% |
| 2021 Q1 | 822.87 Million CNY | 16.47% |
| 2021 Q2 | 839.42 Million CNY | 2.01% |
| 2021 Q3 | 792.72 Million CNY | -5.56% |
| 2021 Q4 | 812.87 Million CNY | 2.54% |
| 2021 FY | 3.26 Billion CNY | 12.99% |
| 2020 Q4 | 706.54 Million CNY | -0.6% |
| 2020 Q2 | 756.25 Million CNY | 5.25% |
| 2020 Q1 | 718.55 Million CNY | -0.19% |
| 2020 FY | 2.89 Billion CNY | 4.14% |
| 2020 Q3 | 710.82 Million CNY | -6.01% |
| 2019 Q4 | 719.94 Million CNY | 15.65% |
| 2019 FY | 2.77 Billion CNY | 3.13% |
| 2019 Q3 | 622.54 Million CNY | -13.58% |
| 2019 Q1 | 714.28 Million CNY | 4.41% |
| 2019 Q2 | 720.38 Million CNY | 0.85% |
| 2018 Q3 | 545.42 Million CNY | -26.69% |
| 2018 FY | 2.69 Billion CNY | 5.8% |
| 2018 Q4 | 684.13 Million CNY | 25.43% |
| 2018 Q1 | 719.33 Million CNY | 3.85% |
| 2018 Q2 | 744.02 Million CNY | 3.43% |
| 2017 Q4 | 692.67 Million CNY | 3.22% |
| 2017 Q2 | 616.21 Million CNY | 8.99% |
| 2017 FY | 2.54 Billion CNY | 24.75% |
| 2017 Q1 | 565.35 Million CNY | 0.67% |
| 2017 Q3 | 671.08 Million CNY | 8.9% |
| 2016 Q3 | 588.36 Million CNY | 34.0% |
| 2016 Q1 | 451.38 Million CNY | 4.85% |
| 2016 FY | 2.04 Billion CNY | 22.23% |
| 2016 Q4 | 561.57 Million CNY | -4.55% |
| 2016 Q2 | 439.07 Million CNY | -2.73% |
| 2015 FY | 1.66 Billion CNY | 15.02% |
| 2015 Q4 | 430.5 Million CNY | -6.1% |
| 2015 Q3 | 458.49 Million CNY | 20.14% |
| 2015 Q2 | 381.63 Million CNY | -4.27% |
| 2015 Q1 | 398.66 Million CNY | -5.61% |
| 2014 Q4 | 422.36 Million CNY | 13.15% |
| 2014 FY | 1.45 Billion CNY | 20.52% |
| 2014 Q1 | 328.76 Million CNY | -3.18% |
| 2014 Q2 | 326.91 Million CNY | -0.56% |
| 2014 Q3 | 373.28 Million CNY | 14.19% |
| 2013 Q2 | 283.51 Million CNY | 5.72% |
| 2013 Q3 | 313 Million CNY | 10.4% |
| 2013 FY | 1.2 Billion CNY | 21.45% |
| 2013 Q4 | 339.55 Million CNY | 8.48% |
| 2013 Q1 | 268.16 Million CNY | -2.8% |
| 2012 Q2 | 224.44 Million CNY | 7.48% |
| 2012 Q3 | 282.35 Million CNY | 25.81% |
| 2012 Q4 | 275.9 Million CNY | -2.29% |
| 2012 FY | 991.52 Million CNY | 26.39% |
| 2012 Q1 | 208.82 Million CNY | -8.27% |
| 2011 Q4 | 227.65 Million CNY | 1.94% |
| 2011 Q1 | 163.08 Million CNY | -8.52% |
| 2011 Q2 | 170.44 Million CNY | 4.51% |
| 2011 Q3 | 223.31 Million CNY | 31.02% |
| 2011 FY | 784.49 Million CNY | 23.0% |
| 2010 Q4 | 178.28 Million CNY | 6.54% |
| 2010 Q2 | 149.7 Million CNY | 5.08% |
| 2010 FY | 637.79 Million CNY | 11.14% |
| 2010 Q1 | 142.47 Million CNY | -10.89% |
| 2010 Q3 | 167.34 Million CNY | 11.78% |
| 2009 Q4 | 159.88 Million CNY | 6.05% |
| 2009 Q2 | 141.41 Million CNY | 16.12% |
| 2009 Q1 | 121.78 Million CNY | -28.29% |
| 2009 FY | 573.85 Million CNY | 4.14% |
| 2009 Q3 | 150.76 Million CNY | 6.62% |
| 2008 FY | 551.04 Million CNY | 17.25% |
| 2008 Q4 | 169.82 Million CNY | 33.43% |
| 2008 Q3 | 127.27 Million CNY | -14.15% |
| 2008 Q1 | 105.68 Million CNY | -29.74% |
| 2008 Q2 | 148.25 Million CNY | 40.28% |
| 2007 Q2 | 110.63 Million CNY | 32.82% |
| 2007 Q3 | 125.61 Million CNY | 13.54% |
| 2007 FY | 469.97 Million CNY | 17.02% |
| 2007 Q4 | 150.41 Million CNY | 19.74% |
| 2007 Q1 | 83.29 Million CNY | -39.11% |
| 2006 Q4 | 136.8 Million CNY | 34.98% |
| 2006 Q1 | 63.53 Million CNY | -46.84% |
| 2006 Q3 | 101.35 Million CNY | 1.43% |
| 2006 FY | 401.61 Million CNY | 21.82% |
| 2006 Q2 | 99.92 Million CNY | 57.28% |
| 2005 Q2 | 84.23 Million CNY | 74.47% |
| 2005 Q1 | 48.28 Million CNY | -60.88% |
| 2005 Q3 | 77.66 Million CNY | -7.79% |
| 2005 Q4 | 119.5 Million CNY | 53.86% |
| 2005 FY | 329.68 Million CNY | 7.09% |
| 2004 Q2 | 62.01 Million CNY | 22.42% |
| 2004 FY | 307.84 Million CNY | 3.06% |
| 2004 Q4 | 123.42 Million CNY | 72.03% |
| 2004 Q3 | 71.74 Million CNY | 15.69% |
| 2004 Q1 | 50.65 Million CNY | -55.29% |
| 2003 Q2 | 72.24 Million CNY | 53.25% |
| 2003 Q3 | 66 Million CNY | -8.65% |
| 2003 Q4 | 113.3 Million CNY | 71.66% |
| 2003 FY | 298.69 Million CNY | 6.47% |
| 2003 Q1 | 47.14 Million CNY | -52.84% |
| 2002 Q4 | 99.96 Million CNY | 30.28% |
| 2002 Q3 | 76.73 Million CNY | 10.88% |
| 2002 Q1 | 35.04 Million CNY | 0.0% |
| 2002 FY | 280.55 Million CNY | 36.26% |
| 2002 Q2 | 69.2 Million CNY | 97.49% |
| 2001 FY | 205.9 Million CNY | 3.43% |
| 2000 FY | 199.07 Million CNY | -9.39% |
| 1999 FY | 219.71 Million CNY | 0.37% |
| 1998 FY | 218.9 Million CNY | 6.58% |
| 1997 FY | 205.38 Million CNY | -8.21% |
| 1996 FY | 223.76 Million CNY | 5.45% |
| 1995 FY | 212.19 Million CNY | 60.81% |
| 1994 FY | 131.95 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 22.81 Billion CNY | 86.523% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 10.05 Billion CNY | 69.425% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 6.73 Billion CNY | 54.322% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 2.31 Billion CNY | -33.027% |
| Aurora Optoelectronics Co.,Ltd. | 327.9 Million CNY | -837.888% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 121.77 Million CNY | -2425.417% |
| NanJing Pharmaceutical Company Limited | 53.58 Billion CNY | 94.261% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.28 Billion CNY | -139.515% |